LINC01912

Across TCGA pan-cancer cohorts, LINC01912 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01912 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01912 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01912 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

UCEC, LUAD, and PAAD are the cancer types where LINC01912 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.613	0.847	<.001	102	view →
LUAD	OS	Tertile	II,III,IV	0.057	0.709	<.001	90	view →
PAAD	DFS	Tertile	All	0.098	0.505	.002	72	view →
BLCA	OS	Tertile	III,IV	0.179	0.587	.004	54	view →
ACC	OS	Tertile	All	0.446	0.822	<.001	45	view →
LGG	DFS	Tertile	All	0.437	0.746	<.001	39	view →
HNSC	OS	Tertile	III,IV	0.487	0.738	.003	39	view →
KIRC	OS	Tertile	All	0.431	0.647	.002	30	view →
SKCM	DFS	Tertile	III,IV	0.126	0.601	.002	18	view →
OV	DFS	Tertile	III,IV	0.300	0.147	.041	12	view →
PRAD	OS	Tertile	All	0.893	0.992	<.001	12	view →
GBM	OS	Tertile	All	0.323	0.438	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01912–UCEC (DFS)

Open the UCEC breakdown →